HomeProductsBioactive CompoundsGPCR & G Protein TargetsProstaglandin ReceptorTerutroban
Chemical structure of CAS 165538-40-9

Terutroban

In Stock•Starting at $67 for 10 mg•Purity ≥ 98%
CAS No.165538-40-9
MDL No.N/A
MFC20H22ClNO4S
MW407.90
InChI KeyHWEOXFSBSQIWSY-MRXNPFEDSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg98%$67In Stock
25 mg98%$146In Stock
50 mg98%$246In Stock
100 mg98%$416In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.165538-40-9
Product NameTerutroban

Biological Targets

TBXA2R
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.

Cerebrovascular diseases (Basel, Switzerland) • Vol. 27, Issue 5 • 2009
PMID: 19372653DOI: 10.1159/000212671

Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat.

British journal of pharmacology • Vol. 155, Issue 2 • 2008
PMID: 18574459PMC: PMC2538696DOI: 10.1038/bjp.2008.256

Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review.

Stroke • Vol. 39, Issue 5 • 2008
PMID: 18369175DOI: 10.1161/STROKEAHA.107.497271

The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.

Cardiovascular research • Vol. 78, Issue 1 • 2008
PMID: 18093985DOI: 10.1093/cvr/cvm112

Documentation